Treggiari Miriam M, Schutz Nicolas, Yanez N David, Romand Jacques-Andre
Department of Anesthesiology, Harborview Medical Center, University of Washington School of Medicine, Seattle 98104, USA, and Department of Anesthesiology, Pharmacology, and Intensive Care, Geneva University Hospital, Switzerland.
Neurocrit Care. 2007;6(2):104-12. doi: 10.1007/s12028-007-0012-1.
Raised intracranial pressure (ICP) has been consistently associated with poor neurological outcome. Our purpose was to systematically review the literature to estimate the association between ICP values and patterns and short- and long-term vital and neurological outcome.
Systematic review of studies identified from MEDLINE, EMBASE, and COCHRANE Registry search from 1966 to 2005, and reference lists of identified articles, with independent assessment of methodological quality, population, ICP values and patterns, management of raised ICP and neurological outcomes. Summary odds ratios (OR) were calculated for the main outcomes using proportional odds models and logistic regression.
Four prospective studies (409 patients) reported the effect of ICP values, and five studies (677 patients) reported the effect of ICP patterns on neurological outcome. No study reported neurological outcomes beyond 1 year. Relative to normal ICP (<20 mmHg), raised ICP was associated with elevated OR of death: 3.5 [95%CI: 1.7, 7.3] for ICP 20-40, and 6.9 [95%CI: 3.9, 12.4] for ICP>40. Raised but reducible ICP was associated with a 3-4-fold increase in the OR of death or poor neurological outcome. Refractory ICP pattern was associated with a dramatic increase in the relative risk of death (OR 114.3 [95%CI: 40.5, 322.3]).
Refractory ICP and response to treatment of raised ICP could be better predictors of neurological outcome than absolute ICP values. Limitations in the design of the studies analyzed precluded identification of the role of ICP monitoring in predicting short- and long-term outcomes.
颅内压(ICP)升高一直与不良神经学预后相关。我们的目的是系统回顾文献,以评估ICP值及模式与短期和长期生命及神经学预后之间的关联。
对1966年至2005年从MEDLINE、EMBASE和COCHRANE注册库检索到的研究进行系统回顾,并查阅已识别文章的参考文献列表,对方法学质量、研究人群、ICP值及模式、ICP升高的处理及神经学预后进行独立评估。使用比例优势模型和逻辑回归计算主要结局的汇总优势比(OR)。
四项前瞻性研究(409例患者)报告了ICP值的影响,五项研究(677例患者)报告了ICP模式对神经学预后的影响。没有研究报告1年以上的神经学预后。相对于正常ICP(<20 mmHg),ICP升高与死亡OR升高相关:ICP为20 - 40时,OR为3.5 [95%CI:1.7, 7.3];ICP>40时,OR为6.9 [95%CI:3.9, 12.4]。可升高但可降低的ICP与死亡或不良神经学预后的OR增加3 - 4倍相关。难治性ICP模式与死亡相对风险的显著增加相关(OR 114.3 [95%CI:40.5, 322.3])。
难治性ICP及对ICP升高的治疗反应可能比绝对ICP值更能预测神经学预后。所分析研究设计中的局限性妨碍了确定ICP监测在预测短期和长期结局中的作用。